Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Illumina advances MRD research portfolio with ultrasensitive duplex sequencing technology

Industry news: on November 9, 2026, Illumina announced an early-access, research-use-only duplex whole-genome sequencing workflow for MRD research, with kits expected to ship in the first quarter of 2027; the company said representative studies showed reproducible ctDNA detection at 2.5 parts per million with 5-10 ng cfDNA input.

Industry news